1. Home
  2. CNC vs ZTS Comparison

CNC vs ZTS Comparison

Compare CNC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centene Corporation

CNC

Centene Corporation

N/A

Current Price

$68.05

Market Cap

34.0B

Sector

Health Care

ML Signal

N/A

Logo Zoetis Inc.

ZTS

Zoetis Inc.

N/A

Current Price

$79.48

Market Cap

29.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNC
ZTS
Founded
1984
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
29.0B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
CNC
ZTS
Price
$68.05
$79.48
Analyst Decision
Buy
Hold
Analyst Count
21
16
Target Price
$74.50
★ $88.38
AVG Volume (30 Days)
★ 3.9M
2.9M
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
★ 2.69%
EPS Growth
N/A
★ 10.05
EPS
★ 5.15
3.08
Revenue
★ $194,777,000,000.00
$9,467,000,000.00
Revenue This Year
$12.83
N/A
Revenue Next Year
N/A
$1.20
P/E Ratio
★ $13.27
$25.54
Revenue Growth
★ 19.44
2.28
52 Week Low
$31.63
$68.92
52 Week High
$72.50
$144.83

Technical Indicators

Market Signals
Indicator
CNC
ZTS
Relative Strength Index (RSI) 51.54 59.78
Support Level $63.36 $72.36
Resistance Level $68.67 $80.17
Average True Range (ATR) 2.70 1.71
MACD -0.21 0.05
Stochastic Oscillator 33.09 66.36

Price Performance

Historical Comparison
CNC
ZTS

About CNC Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: